BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38424533)

  • 1. Molecular mechanism of resveratrol promoting differentiation of preosteoblastic MC3T3-E1 cells based on network pharmacology and experimental validation.
    He Y; Liu F; He M; Long F; Hu D; Chen J; Fang M; Wang Z
    BMC Complement Med Ther; 2024 Feb; 24(1):108. PubMed ID: 38424533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol induces proliferation and differentiation of mouse pre-osteoblast MC3T3-E1 by promoting autophagy.
    Cai W; Sun B; Song C; Liu F; Wu Z; Liu Z
    BMC Complement Med Ther; 2023 Apr; 23(1):121. PubMed ID: 37060066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway.
    Zhao J; Liang G; Yang J; Huang H; Dou Y; Gu Z; Liu J; Zeng L; Yang W
    Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects and mechanism of paeoniflorin in promoting osteogenic differentiation of MC3T3-E1.
    Guo W; Yang XG; Shi YL; Wang H
    J Orthop Surg Res; 2022 Feb; 17(1):90. PubMed ID: 35164817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells.
    Chen XH; Shi ZG; Lin HB; Wu F; Zheng F; Wu CF; Huang MW
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6352-6359. PubMed ID: 31364143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of active components of "Notoginseng Radix et Rhizoma-Drynariae Rhizoma" in treatment of osteoporosis based on network pharmacology and in vitro cell experiment].
    Yang WJ; Huang J; Wang W; Peng LJ; Li JY; Zhu WF
    Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(4):1087-1097. PubMed ID: 36872279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacological study and in vitro studies validation-Molecular dynamics simulation of Cistanche deserticola in promoting periodontitis and bone remodeling.
    Shan C; Wu Z; Xia Y; Ji X; Zhang W; Peng X; Zhao J
    Int Immunopharmacol; 2024 Jun; 135():112299. PubMed ID: 38776853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol protects MC3T3-E1 cells against cadmium-induced suppression of osteogenic differentiation by modulating the ERK1/2 and JNK pathways.
    Mei W; Song D; Wu Z; Yang L; Wang P; Zhang R; Zhu X
    Ecotoxicol Environ Saf; 2021 May; 214():112080. PubMed ID: 33677380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3 promotes the osteoblastic differentiation of MC3T3-E1 cells through the PI3K/Akt signaling pathway.
    Liu Y; Wang H; Zhou XZ; Li N; Guo YC; Chen TP
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSI1 Stabilizes MACF1 to Inhibit Apoptosis of MC3T3-E1 Cells Induced by High Glucose and Promote Osteogenic Differentiation Through Wnt/β-Catenin Signaling Pathway.
    Zou L; Xiang C; Lu M
    Mol Biotechnol; 2023 Jul; 65(7):1085-1095. PubMed ID: 36443618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using network pharmacology and molecular docking verification to explore the mechanism of ursolic acid in the treatment of osteoporosis.
    Yang B; Zhu Q; Wang X; Mao J; Zhou S
    Medicine (Baltimore); 2022 Dec; 101(49):e32222. PubMed ID: 36626454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs.
    Liang G; Zhao J; Pan J; Yang Y; Dou Y; Yang W; Zeng L; Liu J
    J Orthop Surg Res; 2023 Apr; 18(1):312. PubMed ID: 37087476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential circRNA expression profiles during the BMP2-induced osteogenic differentiation of MC3T3-E1 cells.
    Qian DY; Yan GB; Bai B; Chen Y; Zhang SJ; Yao YC; Xia H
    Biomed Pharmacother; 2017 Jun; 90():492-499. PubMed ID: 28395271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Er-xian decoction drug-containing serum promotes Mc3t3-e1 cell proliferation and osteogenic differentiation via regulating BK channel.
    Ren MS; Xie HH; Ding Y; Li ZH; Liu B
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115887. PubMed ID: 36328203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Let-7b downgrades CCND1 to repress osteogenic proliferation and differentiation of MC3T3-E1 cells: An implication in osteoporosis.
    Wang LJ; Cai HQ
    Kaohsiung J Med Sci; 2020 Oct; 36(10):775-785. PubMed ID: 32533643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Erxian Decoction-containing serum on H_2O_2-induced proliferation and osteogenic differentiation of MC3T3-E1 cells via BK channels].
    Ren MS; Ding Y; Li ZH; Wu YM; Huang SM; Luo LL; Zhang YJ; Shi M; Xia XL; Liu B
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2522-2529. PubMed ID: 37282881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-15a-5p plays a role in osteogenic MC3T3-E1 cells differentiation by targeting PDCD4 (programmed cell death 4) via Wnt/β-catenin dependent signaling pathway.
    Wang Q; Miao Y; Qian Z; Chen L; Lu T; Xu Y; Jiang X; Shen Y
    Bioengineered; 2021 Dec; 12(1):8173-8185. PubMed ID: 34672248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hesperidin Anti-Osteoporosis by Regulating Estrogen Signaling Pathways.
    Hu HY; Zhang ZZ; Jiang XY; Duan TH; Feng W; Wang XG
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism and Experimental Verification of
    Liang G; Zhao J; Dou Y; Yang Y; Zhao D; Zhou Z; Zhang R; Yang W; Zeng L
    Front Endocrinol (Lausanne); 2022; 13():866641. PubMed ID: 35355555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.